Literature DB >> 8081471

Automated high-performance liquid chromatographic analysis of (-)-2'-deoxy-3'-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems.

P H Hsyu1, T L Lloyd.   

Abstract

A fully automated HPLC procedure was developed for the analysis of a small volume of perfusion solutions from an isolated perfused rat kidney study. The method involved separation of (-)-2'-deoxy-3'-thiacytidine (3TC) from the matrix by dialysis with 10 mM potassium phosphate buffer pH 3.0. 3TC was subsequently separated from the dialysate as it flowed through a SCX cation-exchange cartridge. The trapped 3TC was then eluted with a mobile phase of 50 mM ammonium acetate buffer (pH 5.5)-methanol (90.5:9.5, v/v) at a flow-rate of 1.0 ml/min for 2 min. The eluent was directed to the HPLC system and chromatographed with a BDS C18 analytical column at a temperature of 45 degrees C. Detection of 3TC was carried out by UV absorption at 274 nm. The procedure was validated from 25 to 10,000 ng/ml. Coefficients of variance (C.V.) of 3TC quality control samples were less than 9%. C.V.s of the standard curve samples were also less than 10% except for the 25 ng/ml samples (11.5%). The mean interpolated concentrations were within 8% of the nominal concentrations for all samples. No interference from concurrent drugs was observed. Preliminary results suggested that this procedure may also be used for human serum and urine samples.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081471     DOI: 10.1016/0378-4347(94)00114-6

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  2 in total

1.  Renal disposition and drug interaction screening of (-)-2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney.

Authors:  K R Sweeney; P H Hsyu; P Statkevich; D R Taft
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

2.  Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure.

Authors:  Ashwin Asari; Heather Iles-Smith; Ya-Chi Chen; Odin J Naderer; Mark A Johnson; Geoffrey J Yuen; Vicky Otto; John A Dunn; Ram Gokal
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.